Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TI-1001
- Development stage
- Unknown
- Lead developer
- TechImmune
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
TI-1001 is a multi-antigen, peptide-based vaccine candidate developed by TechImmune for the prevention of COVID-19. Unlike first-generation vaccines that primarily target the highly mutable Spike protein, TI-1001 incorporates conserved epitopes from the Spike (S), Membrane (M), and Nucleocapsid (N) proteins of SARS-CoV-2. This design aims to provide broad and durable protection against multiple variants by inducing both robust neutralizing antibody responses and long-lasting T-cell immunity. The vaccine is formulated for intramuscular administration and is intended to function as a pan-coronavirus solution by targeting regions of the virus that are less prone to mutation.
- Other names
- TechImmune COVID-19 vaccine
02
Targets
SARS-CoV-2 spikeN (Nucleocapsid protein)M protein (SARS-CoV-2 membrane protein)
Beyond the preview
Go deeper on TI-1001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TI-1001.